Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Hicks

Showing results (1011-1020 of 1,277) with videos related to

Pageof 128
Sort By:
The Annals of Thoracic Surgery|October 1, 1996
Photodynamic therapy for esophageal malignancy: a prospective twelve-year studyJ S McCaughan, E C Ellison, J T Guy, et al.
Molecular Imaging and Biology|June 19, 2025
Poor Diagnostic Performance of the Melanin-Binding Tracer [18 F]MEL050 in Human Melanoma Indicates Biological HeterogeneityRobert E Ware, Damien Kee, Peter Roselt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2018
Prospective, Multisite, International Comparison of <sup>18</sup>F-Fluoromethylcholine PET/CT, Multiparametric MRI, and <sup>68</sup>Ga-HBED-CC PSMA-11 PET/CT in Men with High-Risk Features and Biochemical Failure After Radical Prostatectomy: Clinical Performance and Patient OutcomesLouise Emmett, Ur Metser, Glenn Bauman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 13, 2019
Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution seriesIsaac Goncalves, Kate Burbury, Michael Michael, et al.
AJR. American Journal of Roentgenology|July 15, 2026
Optimal Imaging Strategies After Negative PSMA PET/CT Results in Patients With Prostate Cancer Biochemical Recurrence: <i>AJR</i> Expert Panel Narrative ReviewWonkyu P Choi, Frankis G Almaguel, Elisa Franquet-Elia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2020
Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with <sup>67</sup>CuLachlan E McInnes, Carleen Cullinane, Peter D Roselt, et al.
Health Security|April 28, 2022
Prepared to Act: Lessons Learned by the Special Pathogens Research Network, Based on Collaborations with the NIAID-Led Adaptive COVID-19 Treatment TrialCorri B Levine, Sami Vasistha, Caroline Croyle Persson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 21, 2006
A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancerTrevor Leong, Craig Everitt, Kally Yuen, et al.
Human Genetics|July 28, 2016
Association of kidney structure-related gene variants with type 2 diabetes-attributed end-stage kidney disease in African AmericansMeijian Guan, Jun Ma, Jacob M Keaton, et al.
Lipids in Health and Disease|May 12, 2018
Oxidative modifications of foetal LDL-c and HDL-c lipoproteins in preeclampsiaG León-Reyes, S Espino Y Sosa, R Medina-Navarro, et al.
Pageof 128

Showing results (1011-1020 of 1,277) with videos related to

Sort By:
Pageof 128
The Annals of Thoracic Surgery|October 1, 1996
Photodynamic therapy for esophageal malignancy: a prospective twelve-year studyJ S McCaughan, E C Ellison, J T Guy, et al.
Molecular Imaging and Biology|June 19, 2025
Poor Diagnostic Performance of the Melanin-Binding Tracer [18 F]MEL050 in Human Melanoma Indicates Biological HeterogeneityRobert E Ware, Damien Kee, Peter Roselt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2018
Prospective, Multisite, International Comparison of <sup>18</sup>F-Fluoromethylcholine PET/CT, Multiparametric MRI, and <sup>68</sup>Ga-HBED-CC PSMA-11 PET/CT in Men with High-Risk Features and Biochemical Failure After Radical Prostatectomy: Clinical Performance and Patient OutcomesLouise Emmett, Ur Metser, Glenn Bauman, et al.
European Journal of Nuclear Medicine and Molecular Imaging|June 13, 2019
Characteristics and outcomes of therapy-related myeloid neoplasms after peptide receptor radionuclide/chemoradionuclide therapy (PRRT/PRCRT) for metastatic neuroendocrine neoplasia: a single-institution seriesIsaac Goncalves, Kate Burbury, Michael Michael, et al.
AJR. American Journal of Roentgenology|July 15, 2026
Optimal Imaging Strategies After Negative PSMA PET/CT Results in Patients With Prostate Cancer Biochemical Recurrence: <i>AJR</i> Expert Panel Narrative ReviewWonkyu P Choi, Frankis G Almaguel, Elisa Franquet-Elia, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|October 17, 2020
Therapeutic Efficacy of a Bivalent Inhibitor of Prostate-Specific Membrane Antigen Labeled with <sup>67</sup>CuLachlan E McInnes, Carleen Cullinane, Peter D Roselt, et al.
Health Security|April 28, 2022
Prepared to Act: Lessons Learned by the Special Pathogens Research Network, Based on Collaborations with the NIAID-Led Adaptive COVID-19 Treatment TrialCorri B Levine, Sami Vasistha, Caroline Croyle Persson, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 21, 2006
A prospective study to evaluate the impact of FDG-PET on CT-based radiotherapy treatment planning for oesophageal cancerTrevor Leong, Craig Everitt, Kally Yuen, et al.
Human Genetics|July 28, 2016
Association of kidney structure-related gene variants with type 2 diabetes-attributed end-stage kidney disease in African AmericansMeijian Guan, Jun Ma, Jacob M Keaton, et al.
Lipids in Health and Disease|May 12, 2018
Oxidative modifications of foetal LDL-c and HDL-c lipoproteins in preeclampsiaG León-Reyes, S Espino Y Sosa, R Medina-Navarro, et al.
Pageof 128